Zobrazeno 1 - 10
of 33
pro vyhledávání: '"David E Avigan"'
Autor:
Yi Lin, Madhav Dhodapkar, Aaron P Rapoport, Ajai Chari, Nina Shah, Jack Aiello, David E Avigan, Jesus G Berdeja, Ivan M Borrello, Adam D Cohen, Karthik Ganapathi, Lissa Gray, Damian Green, Amrita Krishnan, Elisabet Manasanch, Nikhil C Munshi, Ajay K Nooka, Eric L Smith, Ravi Vij
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Outcomes in multiple myeloma (MM) have improved dramatically in the last two decades with the advent of novel therapies including immunomodulatory agents (IMiDs), proteasome inhibitors and monoclonal antibodies. In recent years, immunotherapy for the
Externí odkaz:
https://doaj.org/article/cfade875c1d0413986d344c84a15d63a
Autor:
Eva Guinan, David E Avigan, Robert J Soiffer, Nancy J Bunin, Lisa L Brennan, Ilana Bergelson, Spencer Brightman, Al Ozonoff, Patrick J Scannon, Ofer Levy
Publikováno v:
F1000Research, Vol 4 (2015)
Bacterial infection and inflammation contribute significantly to the morbidity and mortality of myeloablative allogeneic hematopoietic cell transplantation (HCT). Endotoxin, a component of the outer membrane of Gram-negative bacteria, is a potent inf
Externí odkaz:
https://doaj.org/article/38a21c9830564e2d829e4fd9bc79c3cd
Autor:
Benjamin A. Derman, Jennifer Cooperrider, Jacalyn Rosenblatt, David E. Avigan, Murtuza Rampurwala, David Barnidge, Ajay Major, Theodore Karrison, Ken Jiang, Aubrianna Ramsland, Tadeusz Kubicki, Andrzej J. Jakubowiak
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract We evaluated the efficacy and safety of 24 cycles of Dara in combination with carfilzomib (K), lenalidomide (R), and dexamethasone (d) without autologous stem cell transplant (ASCT) in newly diagnosed multiple myeloma (NDMM) irrespective of
Externí odkaz:
https://doaj.org/article/83561b47ec1741d597e7e790e6a0d5db
Autor:
Brian M. Russell, David E. Avigan
Publikováno v:
International Journal of Hematology. 117:652-659
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37bc6308375eb328d17ab8fde94b0768
https://doi.org/10.1007/s12185-023-03579-x
https://doi.org/10.1007/s12185-023-03579-x
Autor:
Matthew J. Frigault, Michael R. Bishop, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Noopur Raje, Daniella Cook, Andrew J. Yee, Emma Logan, David E. Avigan, Andrzej Jakubowiak, Kit Shaw, Heather Daley, Sarah Nikiforow, Faith Griffin, Christine Cornwell, Angela Shen, Christopher Heery, Marcela V. Maus
Publikováno v:
Blood Advances. 7:768-777
Relapsed and refractory multiple myeloma (RRMM) is a plasma cell neoplasm defined by progressively refractory disease necessitating chronic and increasingly intensive therapy. Despite recent advances, limited treatment options exist for RRMM. This si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1a9636028e8421071dae6dd97a1f3c
https://doi.org/10.1182/bloodadvances.2022007210
https://doi.org/10.1182/bloodadvances.2022007210
Autor:
Lewis C. Cantley, Steven P. Balk, Sabina Signoretti, Jeffrey M. Karp, Huihui Ye, David E. Avigan, Jacalyn M. Rosenblatt, Pier Paolo Pandolfi, Kathleen Kelly, John G. Clohessy, Elena Levantini, Yugang Wang, Todd M. Morgan, Joshua J. Timmons, Laleh Montaser, John M. Asara, Thomas B. Thornley, Jesse Novak, Olivier Elemento, Lily C. Wang, Athalia R. Pyzer, Brian M. Olson, Katja Helenius, Marina P. Gehring, Natalie Landon-Brace, Aniruddh Solanki, Eva Csizmadia, Kenneth D. Swanson, Akash Patnaik
Increased myeloid CD86-expressing APCs following cabozantinib treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ad926119417a8868654ca0bf010af4
https://doi.org/10.1158/2159-8290.22531907.v1
https://doi.org/10.1158/2159-8290.22531907.v1
Autor:
Lewis C. Cantley, Steven P. Balk, Sabina Signoretti, Jeffrey M. Karp, Huihui Ye, David E. Avigan, Jacalyn M. Rosenblatt, Pier Paolo Pandolfi, Kathleen Kelly, John G. Clohessy, Elena Levantini, Yugang Wang, Todd M. Morgan, Joshua J. Timmons, Laleh Montaser, John M. Asara, Thomas B. Thornley, Jesse Novak, Olivier Elemento, Lily C. Wang, Athalia R. Pyzer, Brian M. Olson, Katja Helenius, Marina P. Gehring, Natalie Landon-Brace, Aniruddh Solanki, Eva Csizmadia, Kenneth D. Swanson, Akash Patnaik
Dexamethasone attenuates the tumor clearance elicited by cabozantinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2136b515a9e025b1af27fd880ded3395
https://doi.org/10.1158/2159-8290.22531892.v1
https://doi.org/10.1158/2159-8290.22531892.v1
Autor:
Lewis C. Cantley, Steven P. Balk, Sabina Signoretti, Jeffrey M. Karp, Huihui Ye, David E. Avigan, Jacalyn M. Rosenblatt, Pier Paolo Pandolfi, Kathleen Kelly, John G. Clohessy, Elena Levantini, Yugang Wang, Todd M. Morgan, Joshua J. Timmons, Laleh Montaser, John M. Asara, Thomas B. Thornley, Jesse Novak, Olivier Elemento, Lily C. Wang, Athalia R. Pyzer, Brian M. Olson, Katja Helenius, Marina P. Gehring, Natalie Landon-Brace, Aniruddh Solanki, Eva Csizmadia, Kenneth D. Swanson, Akash Patnaik
Significant Tumor Shrinkage following cabozantinib treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f1aadb31a9ecb293cd6a7c51f7421a4
https://doi.org/10.1158/2159-8290.22531919.v1
https://doi.org/10.1158/2159-8290.22531919.v1
Autor:
Lewis C. Cantley, Steven P. Balk, Sabina Signoretti, Jeffrey M. Karp, Huihui Ye, David E. Avigan, Jacalyn M. Rosenblatt, Pier Paolo Pandolfi, Kathleen Kelly, John G. Clohessy, Elena Levantini, Yugang Wang, Todd M. Morgan, Joshua J. Timmons, Laleh Montaser, John M. Asara, Thomas B. Thornley, Jesse Novak, Olivier Elemento, Lily C. Wang, Athalia R. Pyzer, Brian M. Olson, Katja Helenius, Marina P. Gehring, Natalie Landon-Brace, Aniruddh Solanki, Eva Csizmadia, Kenneth D. Swanson, Akash Patnaik
Increased CXCL12 within tumor cells by RNA in situ hybridization following cabozantinib treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d6c820b7dc107d7b97c0664ca16f498
https://doi.org/10.1158/2159-8290.22531910.v1
https://doi.org/10.1158/2159-8290.22531910.v1
Autor:
Lewis C. Cantley, Steven P. Balk, Sabina Signoretti, Jeffrey M. Karp, Huihui Ye, David E. Avigan, Jacalyn M. Rosenblatt, Pier Paolo Pandolfi, Kathleen Kelly, John G. Clohessy, Elena Levantini, Yugang Wang, Todd M. Morgan, Joshua J. Timmons, Laleh Montaser, John M. Asara, Thomas B. Thornley, Jesse Novak, Olivier Elemento, Lily C. Wang, Athalia R. Pyzer, Brian M. Olson, Katja Helenius, Marina P. Gehring, Natalie Landon-Brace, Aniruddh Solanki, Eva Csizmadia, Kenneth D. Swanson, Akash Patnaik
Blockade of neutrophil chemotaxis/infiltration rescues cabozantinib-induced tumor regression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2528df0f94914f5d27ffd3a592e09120
https://doi.org/10.1158/2159-8290.22531898
https://doi.org/10.1158/2159-8290.22531898